The Next Frontier for Inhaled Therapies: Low Global Warming Propellants and the Future of pMDI Development
The pharmaceutical inhalation industry stands at a pivotal crossroads. After decades of relative stability following the phase-out of CFCs in the 1990s, a second maj...

















